Karen Feldtmose

Title: Karen Feldtmose: Innovator in Vaginal Pharmaceutical Compositions

Introduction

Karen Feldtmose is a notable inventor based in Pennsburg, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of vaginal pharmaceutical compositions. Her innovative work addresses important health issues and showcases her expertise in pharmaceutical science.

Latest Patents

Karen Feldtmose holds 1 patent for her invention titled "Vaginal pharmaceutical compositions and methods for preparing them." This patent describes compositions that contain an active pharmaceutical ingredient selected from antimicrobial imidazoles and a polysaccharide. The pH of these compositions is maintained between 4.25 and 8. In preferred formulations, the active ingredient includes metronidazole, while the polysaccharide is hypromellose. These compositions are designed for application to vaginal tissue to treat various diseases, such as bacterial vaginosis, or for prophylactic purposes.

Career Highlights

Karen is currently associated with Teva Pharmaceuticals USA, Inc., where she continues to advance her research and development efforts. Her work at Teva Pharmaceuticals reflects her commitment to improving women's health through innovative pharmaceutical solutions.

Collaborations

Karen collaborates with Christine Lynn Bentley, who is also a woman and contributes to the same field. Their partnership exemplifies the importance of teamwork in driving innovation in pharmaceutical research.

Conclusion

Karen Feldtmose's contributions to vaginal pharmaceutical compositions highlight her role as an innovator in the pharmaceutical industry. Her work not only addresses critical health concerns but also demonstrates the impact of dedicated research in improving patient care.